Crystalline therapeutic agent

Details for Australian Patent Application No. 2001272690 (hide)

Owner Pfizer Inc.

Inventors Wood, Albert Shaw; Harris, Laurence, James; Storey, Richard Anthony

Agent Spruson & Ferguson

Pub. Number AU-B-2001272690

PCT Pub. Number WO02/10171

Priority 0018656 28.07.00 GB; 0106464 15.03.01 GB

Filing date 18 July 2001

Wipo publication date 13 February 2002

Acceptance publication date 8 December 2005

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 239/00 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 231/00 Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

Event Publications

8 December 2005 Application Accepted

  Published as AU-B-2001272690

6 April 2006 Standard Patent Sealed

12 February 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001272691

2001272689